MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Renal cell carcinoma treatment
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,551 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,551 works in the cohort · of 4,299,418page 34 of 52

Labels cover 11 of 2,551 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,551 of 2,551 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
Radiation Therapy for Renal Cell Carcinoma
Nicholas G. Zaorsky, Alexander V. Louie, Shankar Siva
2023· letter· en· International Journal of Radiation Oncology*Biology*Physics· Medicine
machine prediction:candidate · noneconsensus · none
2
citations
affno abstractunlabeled
A phase 2 study of investigational TORC1/2 inhibitor TAK-228 and TAK-228 plus investigational PI3Kα-selective inhibitor TAK-117 vs everolimus in adults with advanced or metastatic clear-cell renal cell carcinoma (ccRCC) that has progressed on VEGF-targeted therapy
Toni K. Choueiri, Camillo Porta, C. Suárez Rodríguez, Robert Alter, Piotr Czaykowski, Ignacio Durán +8 more
2017· article· en· Annals of Oncology· Medicine
machine prediction:candidate · noneconsensus · none
2
citations
affunlabeled
Primary tumor ablation in metastatic renal cell carcinoma
Lukas Scheipner, Reha‐Baris Incesu, Simone Morra, Andrea Baudo, Letizia Maria Ippolita Jannello, Carolin Siech +14 more
2024· article· en· Urologic Oncology Seminars and Original Investigations· Medicine
machine prediction:candidate · noneconsensus · none
2
citations
venueno affunlabeled
Genetics and Tumor Microenvironment of Renal Cell Carcinoma
Sari Khaleel, Christopher J. Ricketts, W. Marston Linehan, Mark W. Ball, Brandon J. Manley, Samra Turajilic +2 more
2022· article· en· Société Internationale d’Urologie Journal· Medicine
machine prediction:candidate · noneconsensus · none
2
citations
affunlabeled
Radiation therapy options in kidney cancer
Nicholas G. Zaorsky, Alexander V. Louie, Shankar Siva
2023· review· en· Current Opinion in Supportive and Palliative Care· Medicine
machine prediction:candidate · noneconsensus · none
2
citations
affunlabeled
Abstracts
2016· article· fr· British Journal of Urology· Medicine
machine prediction:candidate · insufficient_payloadconsensus · none
2
citations
affno abstractunlabeled
Renal Medullary Carcinoma
Daniel Y.C. Heng
2017· letter· en· Journal of Oncology Practice· Medicine
machine prediction:candidate · noneconsensus · none
2
citations

How this was built: Screen · Findings · About